Interpretation of wide confidence intervals in meta-analytic estimates: Is the 'Absence of Evidence' 'Evidence of Absence'?
Miller, S. L.; Tuia, J.; Prasad, V.
Show abstract
IntroductionRecently, a Cochrane review by Jefferson et al. on physical interventions to slow the spread of respiratory viruses concluded that, "Wearing masks in the community probably makes little or no difference to the outcome of laboratory-confirmed influenza/SARS-CoV-2 compared to not wearing masks", though this finding had a wide confidence interval. Cochrane issued a rare clarifying statement, fueling controversy. We sought to contextualize the findings of the review by Jefferson et al. MethodsWe searched for consecutive reviews by Cochrane published on or before March 9th, 2023. We included studies where a central finding showed an intervention offered no statistically significant benefit, and ascertained the language used by reviewers to describe that result. We compare this to the report by Jefferson et al., and deemed it consistent or inconsistent with the language of their report. ResultsWe found between November 21st, 2022, and March 9th, 2023, there were 20 Cochrane reviews that met the inclusion criteria. We found that 95% (n = 19) of the reviews used language that was consistent with Jeffersons findings, while 5% (n = 1) used language inconsistent with Jeffersons conclusion, describing the effect of the intervention on the outcome as "unclear". DiscussionMost reviews performed by Cochrane conclude that interventions which fail to show statistically significant benefits make "no difference" have "no effect" or do not "increase or decrease" the outcome, and this occurs despite wide confidence intervals. The conclusions by Jefferson et al. are consistent with Cochrane reporting guidelines and clarification from the organization was unjustified.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production 95%
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 95%
- Citation tracking for systematic literature searching: a scoping review 95%
Similar papers in this journal
Similar papers in this journal
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review 92%
- Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review 92%
- Is artificial intelligence for medical professionals serving the patients? Protocol for a mixed method systematic review on patient-relevant benefits and harms of algorithmic decision-making 90%
Similar papers in this journal
- Adrenaline (epinephrine) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis 90%
- A systematic review of Anakinra, Sarilumab, Siltuximab with meta-analysis of Tocilizumab for Covid-19 90%
- Post-viral parenchymal lung disease following COVID-19 and viral pneumonitis hospitalisation: A systematic review and meta-analysis 89%
Similar papers in this journal
- Comparison of preprints and final journal publications from COVID-19 Studies: Discrepancies in results reporting and spin in interpretation 94%
- Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials 93%
- The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.